FOXP3 identifies regulatory CD25 brightCD4 + T cells in rheumatic joints

68Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Regulatory T cells have recently been implicated in a number of human diseases, including rheumatoid arthritis. To investigate whether the presence of CD25 +CD4 + regulatory T cells is a general finding in arthritic joints, synovial fluid of patients with different rheumatic diseases such as undifferentiated arthritides, systemic rheumatic diseases and reactive arthritis were investigated for the presence of such cells. In 95% of the patients, a higher frequency of CD25 brightCD4 + T cells was found in synovial fluid as compared with peripheral blood. Both in vitro suppression experiments and FOXP3 mRNA analysis confirmed these cells to be natural regulatory T cells. Together with our previous data, we conclude that arthritic joints, irrespective of precise diagnosis and disease duration, are enriched with natural regulatory T cells. These results suggest that suppressor cells migrate to and/or multiply at the sites of inflammation as part of the immune responses' effort to combat injurious inflammation. © 2006 The Authors.

Cite

CITATION STYLE

APA

Cao, D., Börjesson, O., Larsson, P., Rudin, A., Gunnarsson, I., Klareskog, L., … Trollmo, C. (2006). FOXP3 identifies regulatory CD25 brightCD4 + T cells in rheumatic joints. Scandinavian Journal of Immunology, 63(6), 444–452. https://doi.org/10.1111/j.1365-3083.2006.001755.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free